Related Experiment Video
Updated: Dec 2, 2025
07:06
Bone Marrow-derived Macrophage Production
Published on: November 22, 2013
74.7K
Simple method for large-scale production of macrophage activating factor GcMAF
Yoko Nabeshima1, Chiaki Abe1, Takeshi Kawauchi1
1Laboratory of Molecular Life Science, Center of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, 2-2 Minatojima-Minamimachi Chuo-ku, Kobe, 650-0047, Japan.
Scientific Reports
|November 6, 2020
Summary
Researchers developed a new method to produce high-quality human group-specific component protein-derived macrophage activating factor (GcMAF). This simplified process facilitates large-scale GcMAF production for cancer immunotherapy and antiangiogenic therapy research.
Area of Science:
- Biochemistry
- Immunology
- Biotechnology
Background:
- Human group-specific component protein (Gc protein) has common allelic variants Gc1F, Gc1S, and Gc2.
- Gc1 protein can be converted to Gc-protein derived macrophage activating factor (GcMAF), a potential cancer immunotherapy agent.
- Existing GcMAF preparation methods vary, hindering comparative research.
Purpose of the Study:
- To present a simple and practical method for preparing high-quality GcMAF.
- To establish a protocol suitable for large-scale GcMAF production.
Main Methods:
- Overexpression of Gc-protein in ExpiCHO-S cells using serum-free suspension culture.
- Preparation of GcMAF without a de-glycosylation step.
Main Results:
- Successful production of high-quality GcMAF.
- The method avoids the need for de-glycosylation, simplifying the process.
- The protocol is suitable for large-scale production.
Conclusions:
- The presented method offers a straightforward approach to GcMAF preparation.
- This protocol can support functional analysis and clinical testing of GcMAF.
- Facilitates consistent and scalable production of GcMAF for cancer research.
